{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5fa6db4880850a71c9c4bb45/66d9e3e60ef29103a19303fb?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"POMS: A Clinical View","description":"<p><strong>In this issue: </strong>POMS. Pediatric Onset Multiple Sclerosis: children and adolescents with symptoms indicating a diagnosis of multiple sclerosis. Are their presentations different from adult-onset MS? POMS is often associated with higher degrees of activity and inflammation early in the disease.<strong> </strong>How can clinicians most effectively confirm an early MS diagnosis in these young patients? What does the current evidence show about when to prescribe high-efficacy disease modifying therapies? What activity limitations should be placed on patients with POMS?</p><p><br></p><p>Take our&nbsp;<a href=\"https://elit.dkbmed.com/issues/178/test\" rel=\"noopener noreferrer\" target=\"_blank\">post-test</a>&nbsp;to claim CME credits (https://elit.dkbmed.com/issues/209/test)</p><p>Read this podcast's companion newsletter <a href=\"https://elit.dkbmed.com/issues/176\" rel=\"noopener noreferrer\" target=\"_blank\">here</a>. (https://elit.dkbmed.com/issues/208)</p>","author_name":"eMultipleSclerosis Review"}